|
Theralink Technologies Inc (OBMP) |
|
Theralink Technologies Inc
OBMP's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Theralink Technologies Inc 's sales fell
by -72.5 % in I. Quarter 2023 from the same quarter a year ago.
Ranking at No. 996
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.85 %
Theralink Technologies Inc net loss increased from $-8 millions, to $-19 millions in I. Quarter 2023,
• More on OBMP's Growth
|
|
Theralink Technologies Inc realized a net loss in trailing twelve months.
Theralink Technologies Inc realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 18761.98.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on OBMP's Valuation
|
|
|
|
|
Theralink Technologies Inc realized net loss in trailing twelve months.
Theralink Technologies Inc realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 18761.98.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on OBMP's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com